The antibiotic teixobactin—developed a decade ago by Northeastern University professors Kim Lewis and Slava Epstein in ...

Antibiotic resistant bacteria are one of the greatest challenges facing modern medicine, and they are likely to grow greater ...

They have, however, been evaluated for efficacy in mild uncomplicated skin and skin structure infection (uSSSI), including impetigo, SIDs and secondarily infected wounds. Topical antibiotics are ...

“Most antibiotics today have a single target ... synthetic molecules that “share a modular structure that can spontaneously interact with lipid bilayers,” he explains.